Learn More
Invitrogen™ NKp46 Polyclonal Antibody
Goat Polyclonal Antibody
Supplier: Invitrogen™ PA546986
Description
In direct ELISAs, approximately 15% cross-reactivity with recombinant human (rh) NKp46 is observed and less than 1% cross-reactivity with rhNKp80 and rhNKp30 is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
NKp46 (CD335, NCR1, ) is a cytotoxicity-activating receptor that may contribute to the increased efficiency of activated natural killer (NK) cells to mediate tumor cell lysis. NKp46 consists of two Ig-like domains assembled to leukocyte immunoglobulin-like (LIR) and killer inhibitory receptors (KIR).
Specifications
NKp46 | |
Polyclonal | |
Unconjugated | |
NCR1 | |
1-Mar; activating receptor 1; Ar1; CD335; hNKp46; Kilr1; KILR-1; LY94; Ly-94; lymphocyte antigen 94; Lymphocyte antigen 94 homolog; lymphocyte antigen 94 homolog (activating NK-receptor; lymphocyte antigen 94 homolog (activating NK-receptor; NK-p46); mAR-1; MAR1 (mouse activating receptor 1); mNKp46; natural cytotoxicity triggering receptor 1; Natural killer cell p46-related protein; natural killer cell receptor; Ncr1; NK cell-activating receptor; NK receptor KILR-1; NKACTR; Nkp46; NK-p46; NK-p46); rAR-1; rat-activating receptor 1 | |
Goat | |
Antigen affinity chromatography | |
RUO | |
17086 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Lyophilized |
Flow Cytometry, Functional Assay, Western Blot | |
0.2 mg/mL | |
PBS with 5% trehalose and No Preservative | |
Q8C567 | |
NCR1 | |
Mouse myeloma cell line NS0-derived recombinant mouse NKp46/NCR1 Glu22-Asn255. | |
100 μg | |
Primary | |
Mouse | |
Antibody | |
IgG |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.